Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review (Q30640178)

25 June 2017

1 reference

1 reference

title

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review (English)

1 reference

25 June 2017

1 reference

1 reference

Collins SL

1

1 reference

25 June 2017

Moore RA

series ordinal

2

1 reference

25 June 2017

McQuayHJ

series ordinal

3

1 reference

25 June 2017

Wiffen P

series ordinal

4

1 reference

25 June 2017

1 December 2000

1 reference

Journal of Pain and Symptom Management

25 June 2017

1 reference

25 June 2017

20

1 reference

25 June 2017

6

1 reference

25 June 2017

449-458

1 reference

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

A systematic review of antidepressants in neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Developing a database of published reports of randomised clinical trials in pain research

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Pain relief in diabetic neuropathy: the effectiveness of imipramine and related drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Lack of effect of mianserin on the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

A comparison a amitriptyline and maprotiline in the treatment of painful polyneuropathy in diabetics and nondiabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Nortriptyline and fluphenazine in the symptomatic treatment of diabetic neuropathy. A double-blind cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Amitriptyline, but not lorazepam, relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Amitriptyline versus placebo in postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Desipramine relieves postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

Size is everything--large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2800%2900218-9

7 January 2021

10.1016/S0885-3924(00)00218-9

Identifiers

DOI

1 reference

release_6yz7glpzhbcmhmf7e4bxb4qfy4

25 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6yz7glpzhbcmhmf7e4bxb4qfy4

24 November 2022

mapped directly with Wikidata item

1 reference